アルコール依存症治療薬の世界市場（～2026年）

• 英文タイトル：Global Alcohol Addiction Therapeutics Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY02205 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はアルコール依存症治療薬のグローバル市場について調査・分析したレポートです。種類別（CM-1212、CTDP-002、A-705253、ABT-436、ADX-71441、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別アルコール依存症治療薬の競争状況、市場シェア ・世界のアルコール依存症治療薬市場：種類別市場規模 2015年-2020年（CM-1212、CTDP-002、A-705253、ABT-436、ADX-71441、その他） ・世界のアルコール依存症治療薬市場：種類別市場規模予測 2021年-2026年（CM-1212、CTDP-002、A-705253、ABT-436、ADX-71441、その他） ・世界のアルコール依存症治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界のアルコール依存症治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米のアルコール依存症治療薬市場分析：米国、カナダ ・ヨーロッパのアルコール依存症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのアルコール依存症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のアルコール依存症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのアルコール依存症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca Plc、BioCorRx Inc、Bionex Pharmaceuticals LLC、Cerecor Inc、Chronos Therapeutics Ltd、Corcept Therapeutics Inc、Curemark LLC、Eli Lilly and Company、Ethypharm SA、H. Lundbeck A/S、Heptares Therapeutics Ltd、Indivior Plc、Kinnov Therapeutics SAS、Kyorin Pharmaceutical Co Ltd、Lohocla Research Corp、Montisera Ltd、Omeros Corp、Opiant Pharmaceuticals Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Alcohol Addiction Therapeutics Market
The global Alcohol Addiction Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Alcohol Addiction Therapeutics Scope and Market Size
Alcohol Addiction Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alcohol Addiction Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Alcohol Addiction Therapeutics market is segmented into
CM-1212
CTDP-002
A-705253
ABT-436
ADX-71441
Others

Segment by Application, the Alcohol Addiction Therapeutics market is segmented into
Hospital
Clinic
Others

Regional and Country-level Analysis
The Alcohol Addiction Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Alcohol Addiction Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Alcohol Addiction Therapeutics Market Share Analysis
Alcohol Addiction Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alcohol Addiction Therapeutics business, the date to enter into the Alcohol Addiction Therapeutics market, Alcohol Addiction Therapeutics product introduction, recent developments, etc.

The major vendors covered:
AstraZeneca Plc
BioCorRx Inc
Bionex Pharmaceuticals LLC
Cerecor Inc
Chronos Therapeutics Ltd
Corcept Therapeutics Inc
Curemark LLC
Eli Lilly and Company
Ethypharm SA
H. Lundbeck A/S
Heptares Therapeutics Ltd
Indivior Plc
Kinnov Therapeutics SAS
Kyorin Pharmaceutical Co Ltd
Lohocla Research Corp
Montisera Ltd
Omeros Corp
Opiant Pharmaceuticals Inc

レポート目次

---

1 Study Coverage
1.1 Alcohol Addiction Therapeutics Product Introduction
1.2 Market Segments
1.3 Key Alcohol Addiction Therapeutics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Alcohol Addiction Therapeutics Market Size Growth Rate by Type
1.4.2 CM-1212
1.4.3 CTDP-002
1.4.4 A-705253
1.4.5 ABT-436
1.4.6 ADX-71441
1.4.7 Others
1.5 Market by Application
1.5.1 Global Alcohol Addiction Therapeutics Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Alcohol Addiction Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Alcohol Addiction Therapeutics Revenue 2015-2026
2.1.2 Global Alcohol Addiction Therapeutics Sales 2015-2026
2.2 Global Alcohol Addiction Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Alcohol Addiction Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Alcohol Addiction Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Alcohol Addiction Therapeutics Competitor Landscape by Players
3.1 Alcohol Addiction Therapeutics Sales by Manufacturers
3.1.1 Alcohol Addiction Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Alcohol Addiction Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.2 Alcohol Addiction Therapeutics Revenue by Manufacturers
3.2.1 Alcohol Addiction Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Alcohol Addiction Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Alcohol Addiction Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Alcohol Addiction Therapeutics Revenue in 2019
3.2.5 Global Alcohol Addiction Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Alcohol Addiction Therapeutics Price by Manufacturers
3.4 Alcohol Addiction Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Alcohol Addiction Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Alcohol Addiction Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Alcohol Addiction Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Alcohol Addiction Therapeutics Market Size by Type (2015-2020)
4.1.1 Global Alcohol Addiction Therapeutics Sales by Type (2015-2020)
4.1.2 Global Alcohol Addiction Therapeutics Revenue by Type (2015-2020)
4.1.3 Alcohol Addiction Therapeutics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Alcohol Addiction Therapeutics Market Size Forecast by Type (2021-2026)
4.2.1 Global Alcohol Addiction Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Alcohol Addiction Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Alcohol Addiction Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Alcohol Addiction Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Alcohol Addiction Therapeutics Market Size by Application (2015-2020)
5.1.1 Global Alcohol Addiction Therapeutics Sales by Application (2015-2020)
5.1.2 Global Alcohol Addiction Therapeutics Revenue by Application (2015-2020)
5.1.3 Alcohol Addiction Therapeutics Price by Application (2015-2020)
5.2 Alcohol Addiction Therapeutics Market Size Forecast by Application (2021-2026)
5.2.1 Global Alcohol Addiction Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Alcohol Addiction Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Alcohol Addiction Therapeutics Price Forecast by Application (2021-2026)

6 North America
6.1 North America Alcohol Addiction Therapeutics by Country
6.1.1 North America Alcohol Addiction Therapeutics Sales by Country
6.1.2 North America Alcohol Addiction Therapeutics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Alcohol Addiction Therapeutics Market Facts & Figures by Type
6.3 North America Alcohol Addiction Therapeutics Market Facts & Figures by Application

7 Europe
7.1 Europe Alcohol Addiction Therapeutics by Country
7.1.1 Europe Alcohol Addiction Therapeutics Sales by Country
7.1.2 Europe Alcohol Addiction Therapeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Alcohol Addiction Therapeutics Market Facts & Figures by Type
7.3 Europe Alcohol Addiction Therapeutics Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Alcohol Addiction Therapeutics by Region
8.1.1 Asia Pacific Alcohol Addiction Therapeutics Sales by Region
8.1.2 Asia Pacific Alcohol Addiction Therapeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Alcohol Addiction Therapeutics Market Facts & Figures by Type
8.3 Asia Pacific Alcohol Addiction Therapeutics Market Facts & Figures by Application

9 Latin America
9.1 Latin America Alcohol Addiction Therapeutics by Country
9.1.1 Latin America Alcohol Addiction Therapeutics Sales by Country
9.1.2 Latin America Alcohol Addiction Therapeutics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Alcohol Addiction Therapeutics Market Facts & Figures by Type
9.3 Central & South America Alcohol Addiction Therapeutics Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Alcohol Addiction Therapeutics by Country
10.1.1 Middle East and Africa Alcohol Addiction Therapeutics Sales by Country
10.1.2 Middle East and Africa Alcohol Addiction Therapeutics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Alcohol Addiction Therapeutics Market Facts & Figures by Type
10.3 Middle East and Africa Alcohol Addiction Therapeutics Market Facts & Figures by Application

11 Company Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Corporation Information
11.1.2 AstraZeneca Plc Description and Business Overview
11.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Plc Alcohol Addiction Therapeutics Products Offered
11.1.5 AstraZeneca Plc Related Developments
11.2 BioCorRx Inc
11.2.1 BioCorRx Inc Corporation Information
11.2.2 BioCorRx Inc Description and Business Overview
11.2.3 BioCorRx Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 BioCorRx Inc Alcohol Addiction Therapeutics Products Offered
11.2.5 BioCorRx Inc Related Developments
11.3 Bionex Pharmaceuticals LLC
11.3.1 Bionex Pharmaceuticals LLC Corporation Information
11.3.2 Bionex Pharmaceuticals LLC Description and Business Overview
11.3.3 Bionex Pharmaceuticals LLC Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Products Offered
11.3.5 Bionex Pharmaceuticals LLC Related Developments
11.4 Cerecor Inc
11.4.1 Cerecor Inc Corporation Information
11.4.2 Cerecor Inc Description and Business Overview
11.4.3 Cerecor Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Cerecor Inc Alcohol Addiction Therapeutics Products Offered
11.4.5 Cerecor Inc Related Developments
11.5 Chronos Therapeutics Ltd
11.5.1 Chronos Therapeutics Ltd Corporation Information
11.5.2 Chronos Therapeutics Ltd Description and Business Overview
11.5.3 Chronos Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Products Offered
11.5.5 Chronos Therapeutics Ltd Related Developments
11.6 Corcept Therapeutics Inc
11.6.1 Corcept Therapeutics Inc Corporation Information
11.6.2 Corcept Therapeutics Inc Description and Business Overview
11.6.3 Corcept Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Products Offered
11.6.5 Corcept Therapeutics Inc Related Developments
11.7 Curemark LLC
11.7.1 Curemark LLC Corporation Information
11.7.2 Curemark LLC Description and Business Overview
11.7.3 Curemark LLC Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Curemark LLC Alcohol Addiction Therapeutics Products Offered
11.7.5 Curemark LLC Related Developments
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Corporation Information
11.8.2 Eli Lilly and Company Description and Business Overview
11.8.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Eli Lilly and Company Alcohol Addiction Therapeutics Products Offered
11.8.5 Eli Lilly and Company Related Developments
11.9 Ethypharm SA
11.9.1 Ethypharm SA Corporation Information
11.9.2 Ethypharm SA Description and Business Overview
11.9.3 Ethypharm SA Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Ethypharm SA Alcohol Addiction Therapeutics Products Offered
11.9.5 Ethypharm SA Related Developments
11.10 H. Lundbeck A/S
11.10.1 H. Lundbeck A/S Corporation Information
11.10.2 H. Lundbeck A/S Description and Business Overview
11.10.3 H. Lundbeck A/S Sales, Revenue and Gross Margin (2015-2020)
11.10.4 H. Lundbeck A/S Alcohol Addiction Therapeutics Products Offered
11.10.5 H. Lundbeck A/S Related Developments
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Corporation Information
11.1.2 AstraZeneca Plc Description and Business Overview
11.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Plc Alcohol Addiction Therapeutics Products Offered
11.1.5 AstraZeneca Plc Related Developments
11.12 Indivior Plc
11.12.1 Indivior Plc Corporation Information
11.12.2 Indivior Plc Description and Business Overview
11.12.3 Indivior Plc Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Indivior Plc Products Offered
11.12.5 Indivior Plc Related Developments
11.13 Kinnov Therapeutics SAS
11.13.1 Kinnov Therapeutics SAS Corporation Information
11.13.2 Kinnov Therapeutics SAS Description and Business Overview
11.13.3 Kinnov Therapeutics SAS Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Kinnov Therapeutics SAS Products Offered
11.13.5 Kinnov Therapeutics SAS Related Developments
11.14 Kyorin Pharmaceutical Co Ltd
11.14.1 Kyorin Pharmaceutical Co Ltd Corporation Information
11.14.2 Kyorin Pharmaceutical Co Ltd Description and Business Overview
11.14.3 Kyorin Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Kyorin Pharmaceutical Co Ltd Products Offered
11.14.5 Kyorin Pharmaceutical Co Ltd Related Developments
11.15 Lohocla Research Corp
11.15.1 Lohocla Research Corp Corporation Information
11.15.2 Lohocla Research Corp Description and Business Overview
11.15.3 Lohocla Research Corp Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Lohocla Research Corp Products Offered
11.15.5 Lohocla Research Corp Related Developments
11.16 Montisera Ltd
11.16.1 Montisera Ltd Corporation Information
11.16.2 Montisera Ltd Description and Business Overview
11.16.3 Montisera Ltd Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Montisera Ltd Products Offered
11.16.5 Montisera Ltd Related Developments
11.17 Omeros Corp
11.17.1 Omeros Corp Corporation Information
11.17.2 Omeros Corp Description and Business Overview
11.17.3 Omeros Corp Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Omeros Corp Products Offered
11.17.5 Omeros Corp Related Developments
11.18 Opiant Pharmaceuticals Inc
11.18.1 Opiant Pharmaceuticals Inc Corporation Information
11.18.2 Opiant Pharmaceuticals Inc Description and Business Overview
11.18.3 Opiant Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Opiant Pharmaceuticals Inc Products Offered
11.18.5 Opiant Pharmaceuticals Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Alcohol Addiction Therapeutics Market Estimates and Projections by Region
12.1.1 Global Alcohol Addiction Therapeutics Sales Forecast by Regions 2021-2026
12.1.2 Global Alcohol Addiction Therapeutics Revenue Forecast by Regions 2021-2026
12.2 North America Alcohol Addiction Therapeutics Market Size Forecast (2021-2026)
12.2.1 North America: Alcohol Addiction Therapeutics Sales Forecast (2021-2026)
12.2.2 North America: Alcohol Addiction Therapeutics Revenue Forecast (2021-2026)
12.2.3 North America: Alcohol Addiction Therapeutics Market Size Forecast by Country (2021-2026)
12.3 Europe Alcohol Addiction Therapeutics Market Size Forecast (2021-2026)
12.3.1 Europe: Alcohol Addiction Therapeutics Sales Forecast (2021-2026)
12.3.2 Europe: Alcohol Addiction Therapeutics Revenue Forecast (2021-2026)
12.3.3 Europe: Alcohol Addiction Therapeutics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Alcohol Addiction Therapeutics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Alcohol Addiction Therapeutics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Alcohol Addiction Therapeutics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Alcohol Addiction Therapeutics Market Size Forecast by Region (2021-2026)
12.5 Latin America Alcohol Addiction Therapeutics Market Size Forecast (2021-2026)
12.5.1 Latin America: Alcohol Addiction Therapeutics Sales Forecast (2021-2026)
12.5.2 Latin America: Alcohol Addiction Therapeutics Revenue Forecast (2021-2026)
12.5.3 Latin America: Alcohol Addiction Therapeutics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Alcohol Addiction Therapeutics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Alcohol Addiction Therapeutics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Alcohol Addiction Therapeutics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Alcohol Addiction Therapeutics Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Alcohol Addiction Therapeutics Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Alcohol Addiction Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Alcohol Addiction Therapeutics Market Segments
Table 2. Ranking of Global Top Alcohol Addiction Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Alcohol Addiction Therapeutics Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of CM-1212
Table 5. Major Manufacturers of CTDP-002
Table 6. Major Manufacturers of A-705253
Table 7. Major Manufacturers of ABT-436
Table 8. Major Manufacturers of ADX-71441
Table 9. Major Manufacturers of Others
Table 10. Global Alcohol Addiction Therapeutics Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Alcohol Addiction Therapeutics Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Alcohol Addiction Therapeutics Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Alcohol Addiction Therapeutics Sales Market Share by Regions (2015-2020)
Table 14. Global Alcohol Addiction Therapeutics Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Alcohol Addiction Therapeutics Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Alcohol Addiction Therapeutics Sales Share by Manufacturers (2015-2020)
Table 17. Global Alcohol Addiction Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Alcohol Addiction Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alcohol Addiction Therapeutics as of 2019)
Table 19. Alcohol Addiction Therapeutics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Alcohol Addiction Therapeutics Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Alcohol Addiction Therapeutics Price (2015-2020) (USD/Pcs)
Table 22. Alcohol Addiction Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Alcohol Addiction Therapeutics Product Type
Table 24. Date of International Manufacturers Enter into Alcohol Addiction Therapeutics Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Alcohol Addiction Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 27. Global Alcohol Addiction Therapeutics Sales Share by Type (2015-2020)
Table 28. Global Alcohol Addiction Therapeutics Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Alcohol Addiction Therapeutics Revenue Share by Type (2015-2020)
Table 30. Alcohol Addiction Therapeutics Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Alcohol Addiction Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 32. Global Alcohol Addiction Therapeutics Sales Share by Application (2015-2020)
Table 33. North America Alcohol Addiction Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 34. North America Alcohol Addiction Therapeutics Sales Market Share by Country (2015-2020)
Table 35. North America Alcohol Addiction Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Alcohol Addiction Therapeutics Revenue Market Share by Country (2015-2020)
Table 37. North America Alcohol Addiction Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 38. North America Alcohol Addiction Therapeutics Sales Market Share by Type (2015-2020)
Table 39. North America Alcohol Addiction Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 40. North America Alcohol Addiction Therapeutics Sales Market Share by Application (2015-2020)
Table 41. Europe Alcohol Addiction Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Alcohol Addiction Therapeutics Sales Market Share by Country (2015-2020)
Table 43. Europe Alcohol Addiction Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Alcohol Addiction Therapeutics Revenue Market Share by Country (2015-2020)
Table 45. Europe Alcohol Addiction Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Alcohol Addiction Therapeutics Sales Market Share by Type (2015-2020)
Table 47. Europe Alcohol Addiction Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Alcohol Addiction Therapeutics Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Alcohol Addiction Therapeutics Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Alcohol Addiction Therapeutics Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Alcohol Addiction Therapeutics Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Alcohol Addiction Therapeutics Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Alcohol Addiction Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Alcohol Addiction Therapeutics Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Alcohol Addiction Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Alcohol Addiction Therapeutics Sales Market Share by Application (2015-2020)
Table 57. Latin America Alcohol Addiction Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Alcohol Addiction Therapeutics Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Alcohol Addiction Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Alcohol Addiction Therapeutics Revenue Market Share by Country (2015-2020)
Table 61. Latin America Alcohol Addiction Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Alcohol Addiction Therapeutics Sales Market Share by Type (2015-2020)
Table 63. Latin America Alcohol Addiction Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Alcohol Addiction Therapeutics Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Alcohol Addiction Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Alcohol Addiction Therapeutics Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Alcohol Addiction Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Alcohol Addiction Therapeutics Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Alcohol Addiction Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Alcohol Addiction Therapeutics Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Alcohol Addiction Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Alcohol Addiction Therapeutics Sales Market Share by Application (2015-2020)
Table 73. AstraZeneca Plc Corporation Information
Table 74. AstraZeneca Plc Description and Major Businesses
Table 75. AstraZeneca Plc Alcohol Addiction Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. AstraZeneca Plc Product
Table 77. AstraZeneca Plc Recent Development
Table 78. BioCorRx Inc Corporation Information
Table 79. BioCorRx Inc Description and Major Businesses
Table 80. BioCorRx Inc Alcohol Addiction Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. BioCorRx Inc Product
Table 82. BioCorRx Inc Recent Development
Table 83. Bionex Pharmaceuticals LLC Corporation Information
Table 84. Bionex Pharmaceuticals LLC Description and Major Businesses
Table 85. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Bionex Pharmaceuticals LLC Product
Table 87. Bionex Pharmaceuticals LLC Recent Development
Table 88. Cerecor Inc Corporation Information
Table 89. Cerecor Inc Description and Major Businesses
Table 90. Cerecor Inc Alcohol Addiction Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Cerecor Inc Product
Table 92. Cerecor Inc Recent Development
Table 93. Chronos Therapeutics Ltd Corporation Information
Table 94. Chronos Therapeutics Ltd Description and Major Businesses
Table 95. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Chronos Therapeutics Ltd Product
Table 97. Chronos Therapeutics Ltd Recent Development
Table 98. Corcept Therapeutics Inc Corporation Information
Table 99. Corcept Therapeutics Inc Description and Major Businesses
Table 100. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Corcept Therapeutics Inc Product
Table 102. Corcept Therapeutics Inc Recent Development
Table 103. Curemark LLC Corporation Information
Table 104. Curemark LLC Description and Major Businesses
Table 105. Curemark LLC Alcohol Addiction Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Curemark LLC Product
Table 107. Curemark LLC Recent Development
Table 108. Eli Lilly and Company Corporation Information
Table 109. Eli Lilly and Company Description and Major Businesses
Table 110. Eli Lilly and Company Alcohol Addiction Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Eli Lilly and Company Product
Table 112. Eli Lilly and Company Recent Development
Table 113. Ethypharm SA Corporation Information
Table 114. Ethypharm SA Description and Major Businesses
Table 115. Ethypharm SA Alcohol Addiction Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Ethypharm SA Product
Table 117. Ethypharm SA Recent Development
Table 118. H. Lundbeck A/S Corporation Information
Table 119. H. Lundbeck A/S Description and Major Businesses
Table 120. H. Lundbeck A/S Alcohol Addiction Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. H. Lundbeck A/S Product
Table 122. H. Lundbeck A/S Recent Development
Table 123. Heptares Therapeutics Ltd Corporation Information
Table 124. Heptares Therapeutics Ltd Description and Major Businesses
Table 125. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Heptares Therapeutics Ltd Product
Table 127. Heptares Therapeutics Ltd Recent Development
Table 128. Indivior Plc Corporation Information
Table 129. Indivior Plc Description and Major Businesses
Table 130. Indivior Plc Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Indivior Plc Product
Table 132. Indivior Plc Recent Development
Table 133. Kinnov Therapeutics SAS Corporation Information
Table 134. Kinnov Therapeutics SAS Description and Major Businesses
Table 135. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Kinnov Therapeutics SAS Product
Table 137. Kinnov Therapeutics SAS Recent Development
Table 138. Kyorin Pharmaceutical Co Ltd Corporation Information
Table 139. Kyorin Pharmaceutical Co Ltd Description and Major Businesses
Table 140. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 141. Kyorin Pharmaceutical Co Ltd Product
Table 142. Kyorin Pharmaceutical Co Ltd Recent Development
Table 143. Lohocla Research Corp Corporation Information
Table 144. Lohocla Research Corp Description and Major Businesses
Table 145. Lohocla Research Corp Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 146. Lohocla Research Corp Product
Table 147. Lohocla Research Corp Recent Development
Table 148. Montisera Ltd Corporation Information
Table 149. Montisera Ltd Description and Major Businesses
Table 150. Montisera Ltd Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 151. Montisera Ltd Product
Table 152. Montisera Ltd Recent Development
Table 153. Omeros Corp Corporation Information
Table 154. Omeros Corp Description and Major Businesses
Table 155. Omeros Corp Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 156. Omeros Corp Product
Table 157. Omeros Corp Recent Development
Table 158. Opiant Pharmaceuticals Inc Corporation Information
Table 159. Opiant Pharmaceuticals Inc Description and Major Businesses
Table 160. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 161. Opiant Pharmaceuticals Inc Product
Table 162. Opiant Pharmaceuticals Inc Recent Development
Table 163. Global Alcohol Addiction Therapeutics Sales Forecast by Regions (2021-2026) (K Pcs)
Table 164. Global Alcohol Addiction Therapeutics Sales Market Share Forecast by Regions (2021-2026)
Table 165. Global Alcohol Addiction Therapeutics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 166. Global Alcohol Addiction Therapeutics Revenue Market Share Forecast by Regions (2021-2026)
Table 167. North America: Alcohol Addiction Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 168. North America: Alcohol Addiction Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 169. Europe: Alcohol Addiction Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 170. Europe: Alcohol Addiction Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 171. Asia Pacific: Alcohol Addiction Therapeutics Sales Forecast by Region (2021-2026) (K Pcs)
Table 172. Asia Pacific: Alcohol Addiction Therapeutics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 173. Latin America: Alcohol Addiction Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 174. Latin America: Alcohol Addiction Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 175. Middle East and Africa: Alcohol Addiction Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 176. Middle East and Africa: Alcohol Addiction Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 177. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 178. Key Challenges
Table 179. Market Risks
Table 180. Main Points Interviewed from Key Alcohol Addiction Therapeutics Players
Table 181. Alcohol Addiction Therapeutics Customers List
Table 182. Alcohol Addiction Therapeutics Distributors List
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Alcohol Addiction Therapeutics Product Picture
Figure 2. Global Alcohol Addiction Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. CM-1212 Product Picture
Figure 4. CTDP-002 Product Picture
Figure 5. A-705253 Product Picture
Figure 6. ABT-436 Product Picture
Figure 7. ADX-71441 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Alcohol Addiction Therapeutics Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Alcohol Addiction Therapeutics Report Years Considered
Figure 14. Global Alcohol Addiction Therapeutics Market Size 2015-2026 (US$ Million)
Figure 15. Global Alcohol Addiction Therapeutics Sales 2015-2026 (K Pcs)
Figure 16. Global Alcohol Addiction Therapeutics Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Alcohol Addiction Therapeutics Sales Market Share by Region (2015-2020)
Figure 18. Global Alcohol Addiction Therapeutics Sales Market Share by Region in 2019
Figure 19. Global Alcohol Addiction Therapeutics Revenue Market Share by Region (2015-2020)
Figure 20. Global Alcohol Addiction Therapeutics Revenue Market Share by Region in 2019
Figure 21. Global Alcohol Addiction Therapeutics Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Alcohol Addiction Therapeutics Revenue in 2019
Figure 23. Alcohol Addiction Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Alcohol Addiction Therapeutics Sales Market Share by Type (2015-2020)
Figure 25. Global Alcohol Addiction Therapeutics Sales Market Share by Type in 2019
Figure 26. Global Alcohol Addiction Therapeutics Revenue Market Share by Type (2015-2020)
Figure 27. Global Alcohol Addiction Therapeutics Revenue Market Share by Type in 2019
Figure 28. Global Alcohol Addiction Therapeutics Market Share by Price Range (2015-2020)
Figure 29. Global Alcohol Addiction Therapeutics Sales Market Share by Application (2015-2020)
Figure 30. Global Alcohol Addiction Therapeutics Sales Market Share by Application in 2019
Figure 31. Global Alcohol Addiction Therapeutics Revenue Market Share by Application (2015-2020)
Figure 32. Global Alcohol Addiction Therapeutics Revenue Market Share by Application in 2019
Figure 33. North America Alcohol Addiction Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Alcohol Addiction Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Alcohol Addiction Therapeutics Sales Market Share by Country in 2019
Figure 36. North America Alcohol Addiction Therapeutics Revenue Market Share by Country in 2019
Figure 37. U.S. Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Alcohol Addiction Therapeutics Market Share by Type in 2019
Figure 42. North America Alcohol Addiction Therapeutics Market Share by Application in 2019
Figure 43. Europe Alcohol Addiction Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Alcohol Addiction Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Alcohol Addiction Therapeutics Sales Market Share by Country in 2019
Figure 46. Europe Alcohol Addiction Therapeutics Revenue Market Share by Country in 2019
Figure 47. Germany Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Alcohol Addiction Therapeutics Market Share by Type in 2019
Figure 58. Europe Alcohol Addiction Therapeutics Market Share by Application in 2019
Figure 59. Asia Pacific Alcohol Addiction Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Alcohol Addiction Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Alcohol Addiction Therapeutics Sales Market Share by Region in 2019
Figure 62. Asia Pacific Alcohol Addiction Therapeutics Revenue Market Share by Region in 2019
Figure 63. China Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Alcohol Addiction Therapeutics Market Share by Type in 2019
Figure 86. Asia Pacific Alcohol Addiction Therapeutics Market Share by Application in 2019
Figure 87. Latin America Alcohol Addiction Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Alcohol Addiction Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Alcohol Addiction Therapeutics Sales Market Share by Country in 2019
Figure 90. Latin America Alcohol Addiction Therapeutics Revenue Market Share by Country in 2019
Figure 91. Mexico Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Alcohol Addiction Therapeutics Market Share by Type in 2019
Figure 98. Latin America Alcohol Addiction Therapeutics Market Share by Application in 2019
Figure 99. Middle East and Africa Alcohol Addiction Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Alcohol Addiction Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Alcohol Addiction Therapeutics Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Alcohol Addiction Therapeutics Revenue Market Share by Country in 2019
Figure 103. Turkey Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Alcohol Addiction Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Alcohol Addiction Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Alcohol Addiction Therapeutics Market Share by Type in 2019
Figure 110. Middle East and Africa Alcohol Addiction Therapeutics Market Share by Application in 2019
Figure 111. North America Alcohol Addiction Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Alcohol Addiction Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Alcohol Addiction Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Alcohol Addiction Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Alcohol Addiction Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Alcohol Addiction Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Alcohol Addiction Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Alcohol Addiction Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Alcohol Addiction Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Alcohol Addiction Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed

---